SGLT2 drugs also were associated with a 67% lower risk of a ... Both are risk factors for heart attack and stroke. "Another ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

SGLT2 diabetes meds like Jardiance or Farxiga do the same ... Both are risk factors for heart attack and stroke. “Another ...

Empagliflozin, or Empa, is a medication often used to help people with type 2 diabetes manage their blood sugar. Now, ...